DC-T Cell Assays

Dr. Peng Li (Eisai, Japan)

“From our first contact with ProImmune in October 2022, they were very responsive and efficient in their communication where they quickly addressed all our enquiries via email and online meetings, enabling us to make a rapid decision to proceed with our DC-T cell assay project within just one month. What truly stood out was their exceptional turnaround time – the entire project, involving testing of 11 proteins against 42 HLA-typed healthy donors, was completed in approximately six weeks following paperwork finalization and shipment of materials to their UK facility. Beyond the speedy execution, ProImmune demonstrated outstanding scientific support. They scheduled a comprehensive debrief call to help interpret the data and answer our questions, which proved invaluable in helping us reach our project milestones.“

Dr. Caroline Barelle (University of Aberdeen, Scotland)

“We are developing shark single domain therapeutics so identifying and addressing any immunogenicity issues is a critical part of our pre-clinical candidate selection process. Our initial discussions with ProImmune were incredibly informative and helped us define the experimental approach we should adopt. They provided support and information throughout to keep us updated and also succeeded in delivering the data package within our desired and indeed aggressive time frame. In addition, they provided follow up support to take us through the final report to ensure we had a clear understanding of the results obtained. Overall we are very happy with the service and would work with ProImmune again.“